Activity-Based Imaging Probes of the Proteasome
Authors:
- 23 May 2013
- journal article
- review article
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 67 (1) , 91-101
Abstract
Over the years, the proteasome has been extensively investigated due to its crucial roles in many important signaling pathways and its implications in diseases. Two proteasome inhibitors—bortezomib and carfilzomib—have received FDA approval for the treatment of multiple myeloma, thereby validating the proteasome as a chemotherapeutic target. As a result, further research efforts have been focused on dissecting the complex biology of the proteasome to gain the insight required for developing next-generation proteasome inhibitors. It is clear that chemical probes have made significant contributions to these efforts, mostly by functioning as inhibitors that selectively block the catalytic activity of proteasomes. Analogues of these inhibitors are now providing additional tools for visualization of catalytically active proteasome subunits, several of which allow real-time monitoring of proteasome activity in living cells as well as in in vivo settings. These imaging probes will provide powerful tools for assessing the efficacy of proteasome inhibitors in clinical settings. In this review, we will focus on the recent efforts towards developing imaging probes of proteasomes, including the latest developments in immunoproteasome-selective imaging probes.Keywords
This publication has 60 references indexed in Scilit:
- A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude miceBritish Journal of Cancer, 2012
- A bright approach to the immunoproteasome: Development of LMP2/β1i-specific imaging probesBioorganic & Medicinal Chemistry, 2012
- Specific Cell-Permeable Inhibitor of Proteasome Trypsin-like Sites Selectively Sensitizes Myeloma Cells to Bortezomib and CarfilzomibChemistry & Biology, 2011
- Nature of Pharmacophore Influences Active Site Specificity of Proteasome InhibitorsJournal of Biological Chemistry, 2010
- Molecular Basis of the Selectivity of the Immunoproteasome Catalytic Subunit LMP2-Specific Inhibitor Revealed by Molecular Modeling and Dynamics SimulationsThe Journal of Physical Chemistry B, 2010
- Activity-Based Profiling Reveals Reactivity of the Murine Thymoproteasome-Specific Subunit β5tChemistry & Biology, 2010
- A panel of subunit-selective activity-based proteasome probesOrganic & Biomolecular Chemistry, 2010
- Selective Inhibitor of Proteasome's Caspase-like Sites Sensitizes Cells to Specific Inhibition of Chymotrypsin-like SitesChemistry & Biology, 2009
- Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibitionProceedings of the National Academy of Sciences, 2009
- Azido‐BODIPY Acid Reveals Quantitative Staudinger–Bertozzi Ligation in Two‐Step Activity‐Based Proteasome ProfilingChemBioChem, 2008